Smoking doubles the risk of macular degeneration

Smoking doubles the risk of the progressive and irreversible eye condition, macular degeneration, and may account for almost 30,000 cases in the UK, suggests research in the British Journal of Ophthalmology.

The risk of macular degeneration increases with age and is the most common cause of blindness in the UK, affecting around 200,000 elderly people.

The findings are based on a representative sample of over 4,000 people, aged 75 and older, from 49 general practices across Britain.

The participants all underwent a series of detailed eye tests and were asked about their smoking habits, and if they had given up, how long ago. After taking into account other risk factors, such as alcohol consumption and cardiovascular disease, the results showed that current smokers were twice as likely to be visually impaired as non-smokers.

Those who had kicked the habit more than 20 years previously were not at risk.

Based on the numbers of people in the UK who are blind or who are partially sighted as a result of macular degeneration, the authors calculated that smoking was likely to have caused up to 30,000 cases.

"An increased risk of [age related macular degeneration], which is the most commonly occurring cause of blindness in the United Kingdom, is yet another reason for people to stop smoking and governments to develop public health campaigns against this hazard," conclude the authors.

Contact: Professor Astrid Fletcher, Centre for Ageing and Public Health, London School of Hygiene and Tropical Medicine, UK Tel: +44 (0)207 927 2253/4; Mobile: +44 (0)79500 198 805 Email: [email protected]

Click here to view paper in full

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Johns Hopkins study offers new hope for wet AMD patients